Table of Content


Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates and working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 LATAM
1.2.5 MEA
1.3 Forecast calculations
1.4 Data validation
1.5 Data Sources
1.5.1 Secondary
1.5.1.1 Paid Sources
1.5.1.2 Unpaid Sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Antibody therapy industry 360 degree synopsis, 2017 - 2028
2.1.1 Business trends
2.1.2 Type trends
2.1.3 End-use trends
2.1.4 Regional trends
Chapter 3 Antibody Therapy Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2028 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing prevalence of chronic and infectious diseases worldwide
3.3.1.2 Growing research and development activities
3.3.1.3 High rate of adoption and approval in the U and Europe
3.3.1.4 Booming biologics industry
3.3.1.5 Rising applications of antibody therapy
3.3.2 Industry pitfalls & challenges
3.3.2.1 High cost of some monoclonal antibody therapeutics
3.3.2.2 Stringent regulatory framework
3.4 Growth potential analysis
3.4.1 By type
3.4.2 By end-use
3.5 COVID-19 impact analysis
3.6 Pipeline products
3.6.1 Monoclonal antibodies
3.6.2 Antibody drug conjugates
3.7 Regulatory landscape
3.8 Porter’s analysis
3.9 Competitive landscape, 2021
3.10 PESTEL analysis
Chapter 4 Antibody Therapy Market, By Type
4.1 Key segment trends
4.2 Monoclonal antibodies (mAbs)
4.2.1 Market size, by region, 2017 - 2028 (USD Million)
4.2.1.1 Oncology
4.2.1.1.1 Market size, by region, 2017 - 2028 (USD Million)
4.2.1.2 Autoimmune Diseases
4.2.1.2.1 Market size, by region, 2017 - 2028 (USD Million)
4.2.1.3 Infectious diseases
4.2.1.3.1 Market size, by region, 2017 - 2028 (USD Million)
4.2.1.4 Others
4.2.1.4.1 Market size, by region, 2017 - 2028 (USD Million)
4.3 Antibody-drug conjugates (ADCs)
4.3.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 5 Antibody Therapy Market, By End-use
5.1 Key segment trends
5.2 Hospitals
5.2.1 Market size, by region, 2017 - 2028 (USD Million)
5.3 Specialty centers
5.3.1 Market size, by region, 2017 - 2028 (USD Million)
5.4 Others
5.4.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 6 Antibody Therapy Market, By Region
6.1 Key regional trends
6.2 North America
6.2.1 Market size, by country, 2017 - 2028 (USD Million)
6.2.2 Market size, by type, 2017 - 2028 (USD Million)
6.2.2.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.2.3 Market size, by end-use, 2017 - 2028 (USD Million)
6.2.4 U.S.
6.2.4.1 Market size, by type, 2017 - 2028 (USD Million)
6.2.4.1.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.2.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.2.5 Canada
6.2.5.1 Market size, by type, 2017 - 2028 (USD Million)
6.2.5.1.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.2.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.3 Europe
6.3.1 Market size, by country, 2017 - 2028 (USD Million)
6.3.2 Market size, by type, 2017 - 2028 (USD Million)
6.3.2.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.3.3 Market size, by end-use, 2017 - 2028 (USD Million)
6.3.4 Germany
6.3.4.1 Market size, by type, 2017 - 2028 (USD Million)
6.3.4.1.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.3.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.3.5 UK
6.3.5.1 Market size, by type, 2017 - 2028 (USD Million)
6.3.5.1.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.3.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.3.6 France
6.3.6.1 Market size, by type, 2017 - 2028 (USD Million)
6.3.6.1.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.3.6.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.3.7 Italy
6.3.7.1 Market size, by type, 2017 - 2028 (USD Million)
6.3.7.1.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.3.7.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.3.8 Spain
6.3.8.1 Market size, by type, 2017 - 2028 (USD Million)
6.3.8.1.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.3.8.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.4 Asia Pacific
6.4.1 Market size, by country, 2017 - 2028 (USD Million)
6.4.2 Market size, by type, 2017 - 2028 (USD Million)
6.4.2.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.4.3 Market size, by end-use, 2017 - 2028 (USD Million)
6.4.4 China
6.4.4.1 Market size, by type, 2017 - 2028 (USD Million)
6.4.4.1.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.4.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.4.5 Japan
6.4.5.1 Market size, by type, 2017 - 2028 (USD Million)
6.4.5.1.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.4.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.4.6 India
6.4.6.1 Market size, by type, 2017 - 2028 (USD Million)
6.4.6.1.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.4.6.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.4.7 Australia
6.4.7.1 Market size, by type, 2017 - 2028 (USD Million)
6.4.7.1.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.4.7.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.4.8 Singapore
6.4.8.1 Market size, by type, 2017 - 2028 (USD Million)
6.4.8.1.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.4.8.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.5 Latin America
6.5.1 Market size, by country, 2017 - 2028 (USD Million)
6.5.2 Market size, by type, 2017 - 2028 (USD Million)
6.5.2.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.5.3 Market size, by end-use, 2017 - 2028 (USD Million)
6.5.4 Argentina
6.5.4.1 Market size, by type, 2017 - 2028 (USD Million)
6.5.4.1.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.5.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.5.5 Brazil
6.5.5.1 Market size, by type, 2017 - 2028 (USD Million)
6.5.5.1.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.5.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.5.6 Mexico
6.5.6.1 Market size, by type, 2017 - 2028 (USD Million)
6.5.6.1.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.5.6.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.6 Middle East and Africa
6.6.1 Market size, by country, 2017 - 2028 (USD Million)
6.6.2 Market size, by type, 2017 - 2028 (USD Million)
6.6.2.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.6.3 Market size, by end-use, 2017 - 2028 (USD Million)
6.6.4 Saudi Arabia
6.6.4.1 Market size, by type, 2017 - 2028 (USD Million)
6.6.4.1.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.6.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.6.5 South Africa
6.6.5.1 Market size, by type, 2017 - 2028 (USD Million)
6.6.5.1.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.6.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.6.6 UAE
6.6.6.1 Market size, by type, 2017 - 2028 (USD Million)
6.6.6.1.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.6.6.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.6.7 Kuwait
6.6.7.1 Market size, by type, 2017 - 2028 (USD Million)
6.6.7.1.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.6.7.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.6.8 Egypt
6.6.8.1 Market size, by type, 2017 - 2028 (USD Million)
6.6.8.1.1 Market size, by monoclonal antibodies (mAbs), 2017 - 2028 (USD Million)
6.6.8.2 Market size, by end-use, 2017 - 2028 (USD Million)
Chapter 7 Company Profiles
7.1 Competitive dashboard, 2021
7.2 F. Hoffmann-La Roche Ltd
7.2.1 Business overview
7.2.2 Financial data
7.2.3 Product landscape
7.2.4 Strategic outlook
7.2.5 SWOT analysis
7.3 AbbVie, Inc.
7.3.1 Business overview
7.3.2 Financial data
7.3.3 Product landscape
7.3.4 Strategic outlook
7.3.5 SWOT analysis
7.4 Amgen Inc.
7.4.1 Business overview
7.4.2 Financial data
7.4.3 Product landscape
7.4.4 Strategic outlook
7.4.5 SWOT analysis
7.5 Bristol-Myers Squibb Company
7.5.1 Business overview
7.5.2 Financial data
7.5.3 Product landscape
7.5.4 Strategic outlook
7.5.5 SWOT analysis
7.6 Johnson & Johnson Services, Inc.
7.6.1 Business overview
7.6.2 Financial data
7.6.3 Product landscape
7.6.4 Strategic outlook
7.6.5 SWOT analysis
7.7 Seagen
7.7.1 Business overview
7.7.2 Financial data
7.7.3 Product landscape
7.7.4 Strategic outlook
7.7.5 SWOT analysis
7.8 Merck & Co., Inc.
7.8.1 Business overview
7.8.2 Financial data
7.8.3 Product landscape
7.8.4 Strategic outlook
7.8.5 SWOT analysis
7.9 Regeneron Pharmaceuticals Inc.
7.9.1 Business overview
7.9.2 Financial data
7.9.3 Product landscape
7.9.4 Strategic outlook
7.9.5 SWOT analysis
7.10 Novartis AG
7.10.1 Business overview
7.10.2 Financial data
7.10.3 Product landscape
7.10.4 Strategic outlook
7.10.5 SWOT analysis
7.11 AstraZeneca
7.11.1 Business overview
7.11.2 Financial data
7.11.3 Product landscape
7.11.4 Strategic outlook
7.11.5 SWOT analysis
7.12 Eli Lilly and Company
7.12.1 Business overview
7.12.2 Financial data
7.12.3 Product landscape
7.12.4 Strategic outlook
7.12.5 SWOT analysis
7.13 GlaxoSmithKline plc.
7.13.1 Business overview
7.13.2 Financial data
7.13.3 Product landscape
7.13.4 Strategic outlook
7.13.5 SWOT analysis
7.14 Takeda Pharmaceutical Company Limited.
7.14.1 Business overview
7.14.2 Financial data
7.14.3 Product landscape
7.14.4 Strategic outlook
7.14.5 SWOT analysis



List of Tables

Data Tables
Table 1. Global antibody therapy Market, 2017 - 2021 (USD Million)
Table 2. Global antibody therapy Market, 2022 - 2028 (USD Million)
Table 3. Global antibody therapy Market, by type, 2017 - 2021 (USD Million)
Table 4. Global antibody therapy Market, by type, 2022 - 2028 (USD Million)
Table 5. Global antibody therapy Market, by end-use, 2017 - 2021 (USD Million)
Table 6. Global antibody therapy Market, by end-use, 2022 - 2028 (USD Million)
Table 7. Global antibody therapy Market, by region, 2017 - 2021 (USD Million)
Table 8. Global antibody therapy Market, by region, 2022 - 2028 (USD Million)
Table 9. Industry impact forces
Table 10. Monoclonal antibodies (mAbs) market size, by region, 2017 - 2021 (USD Million)
Table 11. Monoclonal antibodies (mAbs) market size, by region, 2022 - 2028 (USD Million)
Table 12. Oncology market size, by region, 2017 - 2021 (USD million)
Table 13. Oncology market size, by region, 2022 - 2028 (USD Million)
Table 14. Autoimmune diseases market size, by region, 2017 - 2021 (USD Million)
Table 15. Autoimmune diseases market size, by region, 2022 - 2028 (USD Million)
Table 16. Infectious diseases market size, by region, 2017 - 2021 (USD Million)
Table 17. Infectious diseases market size, by region, 2022 - 2028 (USD Million)
Table 18. Others market size, by region, 2017 - 2021 (USD Million)
Table 19. Others market size, by region, 2022 - 2028 (USD Million)
Table 20. Antibody-drug conjugates (ADCs) market size, by region, 2017 - 2021 (USD Million)
Table 21. Antibody-drug conjugates (ADCs) market size, by region, 2022 - 2028 (USD Million)
Table 22. Hospitals market size, by region, 2017 - 2021 (USD Million)
Table 23. Hospitals market size, by region, 2022 - 2028 (USD Million)
Table 24. Specialty centers market size, by region, 2017 - 2021 (USD Million)
Table 25. Specialty centers market size, by region, 2022 - 2028 (USD Million)
Table 26. Others market size, by region, 2017 - 2021 (USD Million)
Table 27. Others market size, by region, 2022 - 2028 (USD Million)
Table 28. North America antibody therapy market size, by country, 2017 - 2028 (USD Million)
Table 29. North America antibody therapy market size, by country, 2022 - 2028 (USD Million)
Table 30. North America antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 31. North America antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 32. North America antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 33. North America antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 34. North America antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 35. North America antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 36. U.S. antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 37. U.S. antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 38. U.S. antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 39. U.S. antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 40. U.S. antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 41. U.S. antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 42. Canada antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 43. Canada antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 44. Canada antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 45. Canada antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 46. Canada antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 47. Canada antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 48. Europe antibody therapy market size, by country, 2017 - 2028 (USD Million)
Table 49. Europe antibody therapy market size, by country, 2022 - 2028 (USD Million)
Table 50. Europe antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 51. Europe antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 52. Europe antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 53. Europe antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 54. Europe antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 55. Europe antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 56. Germany antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 57. Germany antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 58. Germany antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 59. Germany antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 60. Germany antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 61. Germany antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 62. UK antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 63. UK antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 64. UK antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 65. UK antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 66. UK antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 67. UK antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 68. France antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 69. France antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 70. France antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 71. France antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 72. France antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 73. France antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 74. Italy antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 75. Italy antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 76. Italy antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 77. Italy antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 78. Italy antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 79. Italy antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 80. Spain antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 81. Spain antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 82. Asia Pacific antibody therapy market size, by country, 2017 - 2028 (USD Million)
Table 83. Asia Pacific antibody therapy market size, by country, 2022 - 2028 (USD Million)
Table 84. Asia Pacific antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 85. Asia Pacific antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 86. Asia Pacific antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 87. Asia Pacific antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 88. Asia Pacific antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 89. Asia Pacific antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 90. China antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 91. China antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 92. China antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 93. China antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 94. China antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 95. China antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 96. Japan antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 97. Japan antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 98. Japan antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 99. Japan antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 100. Japan antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 101. Japan antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 102. India antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 103. India antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 104. India antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 105. India antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 106. India antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 107. India antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 108. Australia antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 109. Australia antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 110. Australia antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 111. Australia antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 112. Australia antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 113. Australia antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 114. Singapore antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 115. Singapore antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 116. Singapore antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 117. Singapore antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 118. Singapore antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 119. Singapore antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 120. Latin America antibody therapy market size, by country, 2017 - 2028 (USD Million)
Table 121. Latin America antibody therapy market size, by country, 2022 - 2028 (USD Million)
Table 122. Latin America antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 123. Latin America antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 124. Latin America antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 125. Latin America antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 126. Latin America antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 127. Latin America antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 128. Brazil antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 129. Brazil antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 130. Brazil antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 131. Brazil antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 132. Brazil antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 133. Brazil antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 134. Mexico antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 135. Mexico antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 136. Mexico antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 137. Mexico antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 138. Mexico antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 139. Mexico antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 140. Argentina antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 141. Argentina antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 142. Argentina antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 143. Argentina antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 144. Argentina antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 145. Argentina antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 146. Middle East and Africa antibody therapy market size, by country, 2017 - 2021 (USD Million)
Table 147. Middle East and Africa antibody therapy market size, by country, 2022 - 2028 (USD Million)
Table 148. Middle East and Africa antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 149. Middle East and Africa antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 150. Middle East and Africa antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 151. Middle East and Africa antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 152. Middle East and Africa antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 153. Middle East and Africa antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 154. Saudi Arabia antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 155. Saudi Arabia antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 156. Saudi Arabia antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 157. Saudi Arabia antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 158. Saudi Arabia antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 159. Saudi Arabia antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 160. South Africa antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 161. South Africa antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 162. South Africa antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 163. South Africa antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 164. South Africa antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 165. South Africa antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 166. UAE antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 167. UAE antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 168. UAE antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 169. UAE antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 170. UAE antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 171. UAE antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 172. Kuwait antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 173. Kuwait antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 174. Kuwait antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 175. Kuwait antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 176. Kuwait antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 177. Kuwait antibody therapy market size, by end-use, 2022 - 2028 (USD Million)
Table 178. Egypt antibody therapy market size, by type, 2017 - 2021 (USD Million)
Table 179. Egypt antibody therapy market size, by type, 2022 - 2028 (USD Million)
Table 180. Egypt antibody therapy market size, by monoclonal antibodies (mAbs), 2017 - 2021 (USD Million)
Table 181. Egypt antibody therapy market size, by monoclonal antibodies (mAbs), 2022 - 2028 (USD Million)
Table 182. Egypt antibody therapy market size, by end-use, 2017 - 2021 (USD Million)
Table 183. Egypt antibody therapy market size, by end-use, 2022 - 2028 (USD Million)

Charts & Figures
FIG 1. Antibody therapy industry 360 degree synopsis
FIG 2. Industry segmentation
FIG 3. Global antibody therapy market, 2017 - 2028 (USD Million)
FIG 4. Growth potential analysis, by type
FIG 5. Growth potential analysis, by end-use
FIG 6. Porter’s analysis
FIG 7. PESTEL analysis
FIG 8. Key segment trends, by type
FIG 9. Key segment trends, by end-use
FIG 10. Key regional trends
FIG 11. Competitive dashboard, 2021